NIH-funded research U01 cooperative agreement

Indiana University center for diabetes after acute pancreatitis

Official title: Indiana University clinical Center for acute pancreatitis and diabetes clinical research network

Funded at Indiana University Indianapolis · NIH-11234596 · Data updated 2026-11-12

This project follows adults who've had acute pancreatitis to find out how and why some develop diabetes afterward.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startSeptember 17, 2020
Project endJuly 31, 2030
Funding year2025
Award (this year)$504,541
NIH project number2U01DK127382-06
Project IDNIH-11234596 on NIH RePORTER

Who could benefit from this research

Could help

Adults (age 21 and older) who recently experienced an episode of acute pancreatitis are the ideal candidates for this project.

Less likely to help

People who never had acute pancreatitis or who already had established, long-standing diabetes before their pancreatitis are unlikely to receive direct benefit from this project.

What this research studies

If you join, you'll be enrolled after a recent episode of acute pancreatitis and have regular blood tests to check blood sugar, insulin, and immune markers, along with imaging and genetic sampling. The team collects clinical information, biospecimens, and scans over time to see who develops diabetes and what type it is. Visits and tests are repeated so researchers can track changes in beta cell function, immune activity, and insulin resistance. The goal is to link these measurements to symptoms and scans to improve future care for people like you.

Why it matters

Potential benefit: If successful, this work could help doctors detect diabetes earlier after pancreatitis and personalize monitoring and care.

How similar studies have gone: Previous observational studies have shown that diabetes can follow pancreatitis, but combining serial immune, imaging, and genetic testing across a multicenter consortium is relatively new.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Fogel, Evan L — Indiana University Indianapolis
  • Study coordinator: Fogel, Evan L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.